A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.
about
Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancerMolecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularSurrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene.Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidenceAbsence of the caveolin-1 P132L mutation in cancers of the breast and other organs.Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularDetection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerA new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer.Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinomaValidation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.A novel environmental DNA approach to quantify the cryptic invasion of non-native genotypes.The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403).Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinibROS1 immunohistochemistry among major genotypes of non-small-cell lung cancerEpidermal growth factor receptor mutations in lung cancers.Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives.Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical PracticeGefitinib for the treatment of non-small-cell lung cancer.Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.First-line management of EGFR-mutated advanced lung adenocarcinoma: recent developments.Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations.Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status.Detection of epidermal growth factor receptor mutations in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction.Rapid detection of the epidermal growth factor receptor mutation in non-small-cell lung cancer for analysis of acquired resistance using molecular beacons.Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report.Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.Impact of smoking on outcome of resected lung adenocarcinoma.Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations.Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patientsDistinct seasonal migration patterns of Japanese native and non-native genotypes of common carp estimated by environmental DNA.
P2860
Q26781810-5CEBD9D2-412B-40C5-A0F3-9B6E02823026Q26828860-D5033284-2C23-4F18-BC7D-EA8D53A36716Q33933021-B639BE19-01F4-4C58-B639-4D9F7ECE502EQ34011705-5E295BB2-FD3E-4015-8A4F-A139DD151366Q34084878-16D129F5-B5A7-499F-8002-3C567652A981Q34158952-3CFFA426-2D77-457C-8814-88DBE55E92E7Q34159011-A718D0A6-5E0D-45AB-B771-6C71D7DEC802Q34467915-53F67519-B470-4836-A2A4-830C06DD39ABQ34621860-3AC198F8-1CEC-4375-B20E-3CD511E5CBD3Q35072998-422AEB5B-D219-453E-8428-8A5E3FA894B2Q35108421-8E83A110-7727-4B63-96AE-B5FED19588F8Q35663913-36CEB2CA-57D1-4253-B5B0-54A6ED28EE0AQ35755589-606294CC-CD7E-4DF4-BEE8-E38CFCE12BCAQ36040599-67B389C1-18AF-43E6-B922-0D5AB05BA2C1Q36102892-048F49E6-0E35-4C95-B5B0-FED00A6EBDF5Q36300517-41F6162F-D9F2-46DE-9186-8AF96711657FQ36494159-DB096704-7D1A-40EC-A178-4B96D675C7DBQ36610291-3A912A34-0F11-4272-91F0-69A68B3FD7AEQ36629689-040AD118-CE2E-438B-97BE-19A569293263Q36817294-44B7D998-01D5-4785-9A94-DD966EA29DEFQ37004639-40E7CC5D-B48B-42C1-98F3-3F54BAFB462FQ37114899-E53BF22F-5854-4F22-94AA-1DE9BBF15EB1Q37144518-64C50611-8982-46F3-9D34-DEEA0F035DB3Q37357287-175C0EFC-D35F-4049-AF44-08D33D117233Q37692130-BD7E2AEE-F011-4A62-93C7-748BF70B00D7Q38061599-6813D82D-8F22-4CAF-B2E7-68D42F1AE738Q38088215-BCF24B74-807D-4619-8E06-EEB299566A4DQ38117105-67224874-C43B-48F7-8546-2C060F772872Q38686009-1EB7B276-68C2-4177-9C9F-5D02E037556BQ39437297-9D54D456-0B73-4EE9-AC8E-E975338B1DBEQ39661497-3A9DAD09-9CF5-42BF-8707-30D9E67EEBE1Q40109306-25B4AE03-3117-45FC-86E1-7DF9955AA636Q40406762-E733150C-4689-4354-86FD-7210892B1794Q40479483-115BD19F-5A29-40A2-93C5-C9CA4A9F59E6Q41503002-3FE3A532-1179-4FB6-A0DF-21819A5E68BEQ41513953-F91142F1-CCCA-4502-8AD4-A5E0B66D4DE0Q41728235-36CBCE00-EA60-453E-B087-1118D0F9E38CQ41757334-0FC6F24E-E1F3-4AFA-A1D7-2E18C7705CD1Q41973777-0FFF6104-367E-43E4-B195-01E4EF7FBD6FQ42671132-2971629B-8D24-42B9-9D74-A962D9D4DFC1
P2860
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@ast
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@en
type
label
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@ast
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@en
prefLabel
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@ast
A rapid, sensitive assay to de ...... sy specimens from lung cancer.
@en
P2093
P2860
P50
P1476
A rapid, sensitive assay to de ...... psy specimens from lung cancer
@en
P2093
Takayuki Kosaka
Toyoaki Hida
Yoshitsugu Horio
P2860
P304
P356
10.2353/JMOLDX.2006.050104
P577
2006-07-01T00:00:00Z